Kai Hoehlig

2.4k total citations
16 papers, 1.0k citations indexed

About

Kai Hoehlig is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kai Hoehlig has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Kai Hoehlig's work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Kai Hoehlig is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers) and Immune Cell Function and Interaction (6 papers). Kai Hoehlig collaborates with scholars based in Germany, United Kingdom and United States. Kai Hoehlig's co-authors include Axel Vater, Simon Fillatreau, Vicky Lampropoulou, Stephen M. Anderton, Toralf Roch, Sven Klußmann, Patrícia Neves, Ulrich Steinhoff, Elisabeth Calderón‐Gómez and Yi Hao and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Kai Hoehlig

14 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kai Hoehlig Germany	13	676	274	210	73	67	16	1.0k
John Copier United Kingdom	15	449 0.7×	379 1.4×	270 1.3×	85 1.2×	129 1.9×	29	902
Jin-Qing Liu United States	20	982 1.5×	290 1.1×	546 2.6×	61 0.8×	91 1.4×	55	1.3k
Marleen Ansems Netherlands	18	365 0.5×	264 1.0×	210 1.0×	46 0.6×	54 0.8×	38	835
Fei Kuang China	13	328 0.5×	336 1.2×	105 0.5×	68 0.9×	71 1.1×	30	822
Anatoli Malyguine United States	20	785 1.2×	268 1.0×	455 2.2×	36 0.5×	85 1.3×	36	1.2k
Peggy A. Bulur United States	13	860 1.3×	302 1.1×	544 2.6×	104 1.4×	72 1.1×	27	1.3k
Ralf Agger Denmark	17	820 1.2×	249 0.9×	166 0.8×	104 1.4×	123 1.8×	43	1.2k
Aaron Y. Chang United States	13	336 0.5×	249 0.9×	405 1.9×	58 0.8×	30 0.4×	18	709
Ehsan Sharif‐Paghaleh United Kingdom	13	408 0.6×	166 0.6×	182 0.9×	32 0.4×	35 0.5×	28	833
Caroline Johnson‐Léger Switzerland	15	656 1.0×	355 1.3×	217 1.0×	57 0.8×	46 0.7×	19	1.2k

Countries citing papers authored by Kai Hoehlig

Since Specialization

Citations

This map shows the geographic impact of Kai Hoehlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Hoehlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Hoehlig more than expected).

Fields of papers citing papers by Kai Hoehlig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Hoehlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Hoehlig. The network helps show where Kai Hoehlig may publish in the future.

Co-authorship network of co-authors of Kai Hoehlig

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Hoehlig. A scholar is included among the top collaborators of Kai Hoehlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Hoehlig. Kai Hoehlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Hoehlig, Kai, et al.. (2025). AON-D21 – Complement C5a-neutralizing human/mouse cross-reactive L-aptamer from bench to phase 2 clinical trial. Immunobiology. 230(4). 153013–153013.

Müller-Redetzky, Holger, Sandra-Maria Wienhold, Birgitt Gutbier, et al.. (2020). Neutralizing Complement C5a Protects Mice with Pneumococcal Pulmonary Sepsis. Anesthesiology. 132(4). 795–807. 22 indexed citations

Ajona, Daniel, Sergio Ortiz‐Espinosa, Haritz Moreno, et al.. (2017). A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discovery. 7(7). 694–703. 187 indexed citations

Bujko, Kamila, et al.. (2017). Signaling of the Complement Cleavage Product Anaphylatoxin C5a Through C5aR (CD88) Contributes to Pharmacological Hematopoietic Stem Cell Mobilization. Stem Cell Reviews and Reports. 13(6). 793–800. 23 indexed citations

Zboralski, Dirk, et al.. (2017). Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade. Cancer Immunology Research. 5(11). 950–956. 135 indexed citations

Yatime, Laure, Christian Maasch, Kai Hoehlig, et al.. (2015). Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer. Nature Communications. 6(1). 6481–6481. 70 indexed citations

Hoehlig, Kai, Lucas Bethge, & Sven Klußmann. (2015). Stereospecificity of Oligonucleotide Interactions Revisited: No Evidence for Heterochiral Hybridization and Ribozyme/DNAzyme Activity. PLoS ONE. 10(2). e0115328–e0115328. 32 indexed citations

Hoehlig, Kai, Kirk W. Johnson, Evgeny Pryazhnikov, et al.. (2015). A novel CGRP‐neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation. British Journal of Pharmacology. 172(12). 3086–3098. 15 indexed citations

Hoehlig, Kai & Sven Klußmann. (2015). Spiegelbildliche Nukleinsäuren als pharmakologische Wirkstoffe. Chemie in unserer Zeit. 49(6). 422–425.

10.

Purschke, Werner G., Kai Hoehlig, Klaus Buchner, et al.. (2014). Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis. Biochemical Journal. 462(1). 153–162. 20 indexed citations

11.

Hoehlig, Kai, Christian Maasch, Nelli Shushakova, et al.. (2013). A Novel C5a-neutralizing Mirror-image (l-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis. Molecular Therapy. 21(12). 2236–2246. 77 indexed citations

12.

Hoehlig, Kai, Ping Shen, Vicky Lampropoulou, et al.. (2012). Activation of CD4⁺Foxp3⁺ regulatory T cells proceeds normally in the absence of B cells during EAE. European Journal of Immunology. 42(5). 1164–1173. 30 indexed citations

13.

Hoehlig, Kai, Vicky Lampropoulou, Toralf Roch, et al.. (2008). Chapter 1 Immune Regulation by B Cells and Antibodies. Advances in immunology. 98. 1–38. 19 indexed citations

14.

Lampropoulou, Vicky, Kai Hoehlig, Toralf Roch, et al.. (2008). TLR-Activated B Cells Suppress T Cell-Mediated Autoimmunity. The Journal of Immunology. 180(7). 4763–4773. 355 indexed citations

15.

Breloer, Minka, Birte Kretschmer, Katja Lüthje, et al.. (2007). CD83 is a regulator of murine B cell function in vivo. European Journal of Immunology. 37(3). 634–648. 48 indexed citations

16.

Breloer, Minka, Birte Kretschmer, Katja Lüthje, et al.. (2007). CD83 is a regular of murine B cell function in vivo. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact